PWPS
ENTA icon

Pinnacle Wealth Planning Services’s Enanta Pharmaceuticals ENTA Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.9K Hold
2,529
– – ﹤0.01% 1480
2026
Q1 		$31.9K Hold
2,529
– – ﹤0.01% 1454
2025
Q4 		$39.9K Buy
+2,529
New +$32.1K ﹤0.01% 1363
2021
Q1 		– Sell
-662
Closed -$28K – 834
2020
Q4 		$28K Buy
+662
New +$29.1K 0.01% 1017

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Pinnacle Wealth Planning Services's ENTA Position: Q2 2026 in Review

Pinnacle Wealth Planning Services held its Enanta Pharmaceuticals (ENTA) position steady in Q2 2026 at 2,529 shares worth $36.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1480.

Pinnacle Wealth Planning Services first reported a position in ENTA in Q4 2020 and has held it in 4 quarters since. The position peaked at $39.9K in Q4 2025. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Pinnacle Wealth Planning Services held 2,529 shares of Enanta Pharmaceuticals worth $36.9K as of Q2 2026.
  • Pinnacle Wealth Planning Services left its Enanta Pharmaceuticals share count unchanged in Q2 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1480 holding.
  • Pinnacle Wealth Planning Services first reported a position in Enanta Pharmaceuticals in Q4 2020 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's Enanta Pharmaceuticals position peaked at $39.9K in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.